Orlistat preparation method

A technology of orlistat and its products, which is applied in the field of drug preparation, can solve the problems of high production cost and complicated manufacturing process, and achieve the effect of low production cost and simple preparation process
CN104744408AInactive Publication Date: 2015-07-01ๆŽ็ฃŠ

Patent Information

Authority / Receiving Office
CN ยท China
Current Assignee / Owner
ๆŽ็ฃŠ
Publication Date
2015-07-01
Estimated Expiration
Not applicable ยท inactive patent
Patent Text Reader

Abstract

The present invention relates to an orlistat preparation method, which concretely comprises: dissolving (3S, 4S)-3-hexyl-4-[(R)-2-hydroxy tridecyl]-2-oxetanone, triphenyl phosphorous and N-formyl-L-leucine in tetrahydrofuran, adding diethyl azodicarboxylate in a dropwise manner under stirring, stirring overnight, taking out the organic phase, carrying out pressure reducing concentration, and carrying out silica gel column chromatography on the remaining material so as to obtain the product orlistat. The orlistat preparation method of the present invention has characteristics of simple preparation process and low production cost.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the field of medicine preparation, in particular to a preparation method of orlistat. Background technique

[0002] Orlistat is currently the only OTC weight loss drug in the world. More than 40,000,000 people around the world have taken it and successfully lost weight. It is currently the best-selling weight loss product. It is effective for weight loss. Orlistat is a potent and long-acting specific gastrointestinal lipase inhibitor. By directly blocking the body's absorption of fat in food, once the intake of heat and fat is less than consumption, Naturally reduce body fat, so as to achieve the purpose of weight loss. It is safe to lose weight, the active ingredients do not enter the blood circulation, do not act on the central nervous system, have fewer side effects, and will not cause dizziness, palpitation, insomnia, dry mouth, etc. Because it is currently in the process of producing orlistat, the manufacturing process i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More